Breast Cancer: Pre- and Postoperative Imaging for Staging

Surgical Oncology Clinics of North America

Volumn 16, Issue 2, 2007, Pages 447-463

  Hansen, Nora M ^a,b   Growney, Alicia ^b  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST BIOPSY; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CARCINOMA IN SITU; ECHOMAMMOGRAPHY; GOLD STANDARD; HUMAN; IMAGING SYSTEM; INTERMETHOD COMPARISON; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REVIEW; SENTINEL LYMPH NODE; UNITED STATES;

BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PREOPERATIVE CARE; ULTRASONOGRAPHY, MAMMARY;

EID: 34249950366     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2007.03.001     Document Type: Review

References (99)

1. Gansler T., and Eyre H. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 1-19
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2007. CA Cancer J Clin 2007;57:43-66.
3. English J. Importance of breast awareness in identification of breast cancer. Nurs Times 99 (2003) 8-29
4. Catalano R., Winett L., Wallack L., et al. Evaluating a campaign to detect early stage breast tumors in the United States. Eur J Epidemiol 18 (2003) 545-550
5. Zonderland H. The role of ultrasound in the diagnosis of breast cancer. Semin Ultrasound CT MR 21 (2000) 317-324
6. Santiago R.J., Wu L., Harris E., et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for Stage I and II breast carcinoma: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 58 (2004) 233-240
7. Ries L., Eisner M., Kosary C., et al. SEER cancer statistics review, 1975-2002 (2005), National Cancer Institute, Bethesda (MD)
8. Winchester D., and Cox J. Standards for diagnosis and management of invasive breast carcinoma. American College of Radiology. American College of Surgeons. College of American Pathologists. Society of Surgical Oncology. CA Cancer J Clin 48 (1998) 83-107
9. Holland R., Connolly J., Gelman R., et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8 (1990) 113-118
10. Ghossein N., Alpert S., Barba J., et al. Breast cancer. Importance of adequate surgical excision prior to radiotherapy in the local control of breast cancer in patients treated conservatively. Arch Surg 127 (1992) 411-415
11. Recht A., Come S., Henderson I., et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334 (1996) 1356-1361
12. Coburn N., Chung M., Fulton J., et al. Decrease breast cancer tumor size, stage, and mortality in Rhode Island: an example of a well-received population. Cancer Control 11 4 (2004) 222-230
13. Fracheboud J., Otto S., van Dijck J., et al. Decreased rates of advanced breast cancer due to mammography screening in the Netherlands. Br J Cancer 91 (2004) 861-867
14. Orel S.G., and Schnall M.D. MR Imaging of the breast for the detection, diagnosis and staging of breast cancer. Radiology 220 (2001) 13-30
15. Linver M.N., Osuch J.R., Brenner R.J., et al. The mammography audit: a primer for the mammography quality standards act. AJR Am J Roentgenol 165 (1995) 19-25
16. Homer M.J. Why mammography is perceived to be "different". In: Homer M.J. (Ed). Mammographic interpretation. A practical approach (1997), McGaw-Hill, New York 4-10
17. Berg W., Gutierrez L., NessAiver M., et al. Diagnostic accuracy of mammography, clinical examination, US and MR imaging in preoperative assessment of breast cancer. Radiology 233 (2004) 830-849
18. Pisano E.D., Gatsonis C., Hendrick E., et al. Diagnostic performance of digital versus film mammography for breast cancer screening. N Engl J Med 27 313 (2005) 177-183
19. Chandawarkar R., and Shinde S. Preoperative diagnosis of carcinoma of the breast: is a "cost-cutter" algorithm tenable?. J Surg Oncol 64 (1997) 153-158
20. Berg W. Imaging the local extent of disease. Seminars in Breast Disease 4 (2001) 153-173
21. Venta L., Dudiak C., Salomon C., et al. Sonographic evaluation of the breast. Radiographics 14 (1994) 29-50
22. Moon W., Nol D., and Im J. Multifocal, multicentric, and contralateral breast cancers: bilateral whole-breast ultrasound in the preoperative evaluation of patients. Radiology 254 (2002) 569-576
23. Berg W.A. Rationale for a trial of screening breast ultrasound. American College of Radiology Imaging Network ACRIN, 6666. AJR Am J Roentgenol 180 5 (2003) 1225-1228
24. Lagios M.D. Multicentricity of breast carcinoma demonstrated by routine correlated serial multicentric breast carcinoma subgross and radiographic examination. Cancer 40 4 (1997) 1726-1734
25. Holland R., Solke H.J., Veling S.H., et al. Histologic multifocality of tis, T1-2 breast carcinomas: implications for clinical trials of breast-conserving surgery. Cancer 56 (1985) 979-990
26. Schwartz G.F., Patchesfsky A.S., Feig S.A., et al. Multicentricity of non-palpable breast cancer. Cancer 65 (1980) 2913-2916
27. Berg W., and Gilbreath P. Multicentric and multifocal cancer: whole-breast US in preoperative evaluation. Radiology 214 (2000) 59-66
28. Vargas H., Khalkhali I., Gonzalez K., et al. Use of preoperative breast ultrasonography for mapping of breast cancer extent improves resection margins during breast conservation surgery. Arch Surg 139 (2004) 863-869
29. Mandelson M., Oestreicher N., Porter P., et al. Breast density as a predictor of mammographic detection: comparison of interval and screen-detected cancers. J Natl Cancer Inst 92 (2000) 1081-1087
30. Trop I., David J., and Lalonde L. Breast cancer staging: the role of the radiologist. Can Assoc Radiol J 56 5 (2005) 324-331
31. Smith M., Allison K., and Shaw de Paredes E. Nonmammographic evaluation of the extent of breast carcinoma. Semin Ultrasound CT MR 27 (2006) 308-319
32. Butler R., Venta L., Wiley E., et al. Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 172 (1999) 325-330
33. Reddy D.H., and Mendelson E.B. Incorporating new imaging models in breast cancer management. Curr Treat Options Oncol 6 (2005) 135-145
34. Van Goethem M., Tjalma W., Schelfout K., et al. Magnetic resonance imaging in breast cancer. Eur J Surg Oncol 32 9 (2006) 901-910
35. Frouge C., Guinebretiere J., Contesso G., et al. Correlation between contrast enhancement in dynamic magnetic resonance imaging of the breast and tumor angiogenesis. Invest Radiol 29 (1994) 1043-1049
36. Nagy J., Brown L., Senger D., et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 948 (1989) 305-336
37. Heywang-Kobrunner S., Viebweg P., Heinig A., et al. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 32 1 (1997) 94-108
38. Liberman L., Morris E., Dershaw D., et al. MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 180 (2003) 901-910
39. Fischer U., Kopka L., and Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213 (1999) 881-888
40. Nunes L., Schnall M., Orel S., et al. Breast MR imaging: interpretation model. Radiology 202 (1997) 833-841
41. Kuhl C., Bieling H., Gieseke J., et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 203 (1997) 137-144
42. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17 (1999) 110-119
43. Kuhl C. MRI of the breast. Advances in Magnetic Resonance Imaging Contrast 5 (1998) 56-69
44. Sasaki M., Ichiya Y., Kuwabara Y., et al. The usefulness of FDG positron emission tomography in the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography. Eur J Nucl Med 23 (1996) 741-747
45. Dehdashti F., Mortimor J.E., Siegel B.A., et al. Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FSG-PET and in vitro receptor assays. J Nucl Med 36 (1995) 1766-1774
46. Hoh C.K., Hawkins R.A., Glaspy J.A., et al. Cancer detection with whole-body PET using 2 [18-F] fluoro-2-deoxy-D glucose. J Comput Assist Tomogr 17 (1993) 582-589
47. Noh D.Y., Yun I.J., Kim J.S., et al. Diagnostic value of positron emission tomography for detecting breast cancer. World J Surg 22 (1998) 223-228
48. Avril N., Rose C.A., Schelling M., et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18 (2000) 3495-3502
49. Macmillan R., Rampaul R., Lewis S., et al. Preoperative ultrasound-guided node biopsy and sentinel node augmented node sample is best practice. Eur J Cancer 40 (2004) 176-178
50. Sharma A., Fidias P., Hayman L., et al. Patterns of lymphadenopathy in thoracic malignancies. Radiographics 24 (2004) 419-434
51. Sato K., Tamaki K., Tsuda H., et al. Utility of axillary ultrasound examination to select breast cancer patients suited for optimal sentinel node biopsy. Am J Surg 187 (2004) 679-683
52. Ikeda D., and Anderson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology 172 (1989) 661-666
53. Stomper P., and Margolin F. Ductal carcinoma in situ: the mammographer's perspective. AJR Am J Roentgenol 162 (1994) 585-591
54. Dershaw D., Abramson A., and Kinne D. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 170 2 (1989) 411-415
55. Coombs J., Hubbard E., Hudson K., et al. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease. Am Surg 63 (1997) 1079-1083
56. Lagios M., Westdahl P., Margolin F., et al. Ductal carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failure. Cancer 50 (1982) 1309-1314
57. Holland R., and Hendricks J. Micro calcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 11 (1994) 181-192
58. Orel S., Reynolds C., Schnall M., et al. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology 205 (1997) 429-436
59. Soo M., Baker J., and Rosen E. Sonographic detection and sonographic guided biopsy of breast micro calcifications. AJR Am J Roentgenol 180 (2003) 941-948
60. Burhenne H., Burhenne L., Goldberg F., et al. Interval breast cancers in the screening mammography program of British Columbia: analysis and classification. AJR Am J Roentgenol 162 (1994) 1067-1071
61. Robertson C. A private breast imaging practice: medical audit of 25,788 screening and 1,077 diagnostic examinations. Radiology 187 (1993) 75-79
62. Kerlikowske K., Grady D., Barclay J., et al. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 276 (1996) 33-38
63. Kolb T., Lichy J., and Newhouse J. Comparison of the performance of screening mammography, physical examination, and breast ultrasound and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225 (2002) 165-175
64. Harms S., Flamig D., Hesley K., et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187 (1993) 493-501
65. Orel S., Schnall M., Powell C., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196 (1995) 115-122
66. Hlawatsch A., Teifke A., Schmidt M., et al. Preoperative assessment of breast cancer: sonography versus MR imaging. AJR Am J Roentgenol 179 (2002) 1493-1501
67. Fischer V., Kopka L., Brinck V., et al. Prognostic value of contrast-enhanced MR mammography in patients with breast cancer. Eur Radiol 7 (1997) 1002-1005
68. Mendelson E., Harris K., Doshu N., et al. Infiltrating lobular carcinoma: mammographic patterns with pathologic correlation. AJR Am J Roentgenol 153 (1989) 265-271
69. Gilles R., Guinebretiere J., Lucidarme O., et al. Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191 (1994) 625-631
70. Schelfout K., Van Goethem M., Kersschot E., et al. Preoperative breast MRI in patients with invasive lobular breast cancer. Eur Radiol 14 (2004) 1209-1216
71. Qayyum A., Birdwell R., Daniel B., et al. MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178 (2002) 1227-1232
72. Weinstein S., Orel S., Heller R., et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol 176 (2001) 399-406
73. Boetes C., Veltman J., Van Die L., et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86 (2004) 31-37
74. Rodenko G., Harms S., Pruneda J., et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol 167 (1996) 1415-1419
75. Kneeshaw P., Turnbull L., Smith A., et al. Dynamic contrast enhanced magnetic resonance imaging aids the surgical management of invasive lobular breast cancer. Eur J Surg Oncol 29 (2003) 32-37
76. European Organization for Research and Treatment of Cancer (EORTC) breast cancer cooperative group. EORTC manual for clinical research and treatment in breast cancer. 4th edition (2000), Excerpta Medica, Almere (the Netherlands)
77. Tilakaratna A., Rodrigo T., and de Silva M. Extensive intraduct component in invasive duct carcinoma of the breast: prevalence and significance in a south Asian setting. Indian J Cancer 37 (2000) 1-3
78. Mumtaz H., Hall-Craggs M., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169 (1997) 417-424
79. Boyages J., Recht A., Connolly J., et al. Early breast cancer: predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Raodiother Oncol 19 (1990) 29-41
80. Schnitt S., Abner A., Gelman R., et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 74 (1994) 1746-1751
81. Gage I., Schnitt S., Nixon A., et al. Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy. Cancer 78 (1996) 1921-1928
82. Stomper P., and Commolly J. Mammographic features predicting an extensive intraductal component in early-stage infiltrating ductal carcinoma. AJR Am J Roentgenol 158 (1992) 269-272
83. Satake H., Shimamoto K., Sawaki A., et al. Role of ultrasonography in the detection of intraductal spread of breast cancer: correlation with pathologic findings, mammography and MR imaging. Eur Radiol 10 (2000) 1726-1732
84. Van Goethem M., Schelfout K., Kersschot E., et al. Enhancing area surrounding breast carcinoma on MR mammography: comparison with pathological examination. Eur Radiol 14 (2004) 1363-1370
85. Boetes C., Mus R., and Holland R. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197 (1995) 743-747
86. Soderstrom C., Harms S., Copit D., et al. Three-dimensional RODEO breast MR imaging of lesions containing ductal carcinoma in situ. Radiology 201 (1996) 427-432
87. Kerslake R., Carleton P., Fox J., et al. Dynamic gradient echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 50 (1995) 440-454
88. Hungness E., Safa M., Shaughnessy E., et al. Bilateral synchronous breast cancer: mode of detection and comparison of histology features between two breasts. Surgery 128 (2000) 702-707
89. Broet P., de la Rochefordiere A., Scholl S., et al. Contralateral breast cancer: annual incidence and risk parameters. J Clin Oncol 13 (1995) 1578-1583
90. Healey E., Cook E., Orav E., et al. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol 11 (1993) 1545-1552
91. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 30 (2004) 501-507
92. Van Goethem M., Schelfout K., Dijckmans L., et al. MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound. Eur Radiol 14 (2004) 809-816
93. Drotman M.B., Machnicki S.C., Schwartz L.H., et al. Breast cancer: assessing the use of routine pelvic CT in patient evaluation. AJR Am J Roentgenol 176 6 (2001) 1433-1436
94. Norum J., and Andreassen T. Screening for metastatic disease in newly diagnosed breast cancer patients. What is cost-effective?. Anticancer Res 20 3B (2000) 2193-2196
95. Rojas M.P., Telaro E., Russo A., et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev 1 (2005) CD001768
96. Joseph E., Hyacinthe M., Lyman G.H., et al. Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer. Ann Surg Oncol 5 6 (1999) 522-528
97. Isasi C.R., Moradel R.M., and Blaufox M.D. A meta-analysis of FDG-PET for the evaluation of breast cancer recurrence and metastases. Breast Cancer Res Treat 90 (2005) 105-112
98. Khatcheressian J.L., Wolff A.C., Smith T.J., et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24 31 (2006) 5091-2097
99. National Comprehensive Cancer Network, Inc. NCCN breast cancer clinical practice guidelines in oncology, version 2.2007. 2006. Available at: www.nccn.org. Accessed April 4, 2007.